Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Moodys
Cerilliant
AstraZeneca
UBS
Citi
Teva
Merck
Chinese Patent Office

Generated: May 24, 2018

DrugPatentWatch Database Preview

MPI INDIUM DTPA IN 111 Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Mpi Indium Dtpa In 111 patents expire, and when can generic versions of Mpi Indium Dtpa In 111 launch?

Mpi Indium Dtpa In 111 is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in MPI INDIUM DTPA IN 111 is indium in-111 pentetate disodium. There are twenty-three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the indium in-111 pentetate disodium profile page.
Summary for MPI INDIUM DTPA IN 111
US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Clinical Trials: 57
DailyMed Link:MPI INDIUM DTPA IN 111 at DailyMed
Drug patent expirations by year for MPI INDIUM DTPA IN 111

US Patents and Regulatory Information for MPI INDIUM DTPA IN 111

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare MPI INDIUM DTPA IN 111 indium in-111 pentetate disodium INJECTABLE;INTRATHECAL 017707-001 Feb 18, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
Moodys
Argus Health
Merck
Dow
Covington
Healthtrust
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.